查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856281

α發射體市場按應用、最終用戶、發射體類型、裝置類型、輸送方式、純度等級和偵測技術分類－2025-2032年全球預測

Alpha Emitters Market by Application, End User, Emitter Type, Equipment Type, Delivery Mode, Purity Grade, Detection Technique - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，α 發射體市場規模將達到 48.1 億美元，複合年成長率為 20.80%。

主要市場統計數據
基準年 2024 10.6億美元
預計年份：2025年 12.8億美元
預測年份：2032年 48.1億美元
複合年成長率 (%) 20.80%

全面介紹α放射性核素，重點闡述影響策略決策的科學進展、監管動態與操作考量。

α放射性核種已從小眾科學研究領域發展成為臨床、環境、產業和科研領域的重要工具。本書概述了當前α放射性核素的技術、監管和商業性格局，重點關注放射性核素生產創新與安全處理、檢測和應用方面不斷變化的需求之間的相互作用。本書闡明了α放射性核種的提案：其獨特的放射生物學特性使其能夠實現高度局部的能量沉積，​​用於治療；同時，其特徵訊號也有助於進行針對性的環境和工業監測。

技術創新、監管趨嚴以及供應鏈重組的韌性將改變α放射性物質的採用方式。

由於技術、政策和需求三方力量的共同作用，α放射性核種的應用格局正在改變性變化。同位素生產和發生器設計的突破性進展消除了一些歷史瓶頸，而檢測器靈敏度和特異性的提升則拓展了其在臨床治療和環境監測方面的應用範圍。同時，臨床研究人員對標靶α療法的探索以及環境和產業相關人員對更高保真度檢測能力的追求，也進一步推動了這些技術進步。

2025年美國貿易行動的累積後果將推動採購結構調整、國內產能投資和一體化供應鏈風險緩解。

美國將於2025年實施新的關稅，將對α排放生態系統產生累積影響，波及臨床、工業和研究領域的相關人員採購計畫、物流和成本結構。進口關稅及相關貿易措施增加了依賴國際供應鏈取得同位素、發生器零件和專用設備的機構的交易複雜性。這些措施迫使採購團隊重新評估總到岸成本，並將交貨延誤和海關合規相關的風險溢價納入成本核算。

透過深度細分洞察，從策略層面協調應用需求、上市設備類型、設備模式、給藥形式、純度差異和檢測技術。

細分市場洞察揭示了差異化的價值鍊和應用管道，這對策略規劃至關重要。就應用類別而言，環境監測活動涵蓋空氣監測、土壤採樣和水質監測，並且往往優先考慮檢測靈敏度和法規遵循性，以滿足長期監測計畫的需求。工業檢測依賴於無損檢測和厚度測量，堅固耐用的檢測器和標準化的輻射源能夠實現快速、可重複的測試。這些特定應用的需求影響採購優先順序、品質保證實務和技術規格。

實際可行的區域洞察，揭示美洲、歐洲、中東和非洲以及亞太地區在採納、生產和監管方面不同的優先事項。

區域動態凸顯了美洲、歐洲、中東和非洲以及亞太地區不同的戰略重點和執行管道。在美洲，大量先進的臨床研究中心和工業檢測服務提供者推動了對高純度發射設備和先進檢測系統的強勁需求，加上法規環境日益重視供應安全和臨床檢測的完整性，促使各方加大對國內能力建設的投資，並推動學術中心、醫療系統和商業供應商之間建立合作聯盟，以確保治療方案和監測舉措的連續性。

對主要企業進行競爭考察，重點關注其透過整合供應鏈、技術平台、智慧財產權和服務主導的競爭定位所實現的差異化優勢。

α粒子發射設備的競爭取決於技術專長、監管經驗以及提供可靠供應鏈的能力。領先企業透過提供綜合產品脫穎而出，這些產品將同位素和發生器製造、檢驗的檢測技術以及全面的合規服務相結合。其他企業則專注於特定領域，例如高純度製造流程、可擴展的發生器平台以及適用於工業環境的堅固耐用的檢測器。製造商、設備供應商和醫療機構之間的策略夥伴關係關係日益普遍，從而能夠實現快速的臨床檢測、協調的供應鏈物流和風險共用機制。

為行業領導者提供行動建議，以建立具有韌性的供應鏈，加快採用速度，並使創新與合規性和最終用戶需求保持一致。

該領域的領導者應優先考慮一系列切實可行的措施，將機會轉化為永續的優勢。首先，投資建構具有韌性的供應鏈架構，融合策略庫存管理以及國內外生產能力的夥伴關係，以降低跨境中斷和關稅波動帶來的風險。其次，優先考慮合規性和員工素質，建立認證培訓項目、健全的品管系統和透明的文件記錄，以滿足不斷變化的監管要求。

透過透明、專家主導的調查方法，結合一手訪談、二手檢驗、跨領域綜合分析和情境分析，獲得可靠的洞察。

本報告的調查方法結合了第一手資料收集、專家訪談和嚴謹的二手資料分析，旨在全面展現α粒子發射設備的現狀。第一手資料收集包括與臨床研究人員、環境監測從業人員、工業檢測工程師、設備製造商和監管專家進行結構化對話，以了解實際應用中的限制和推動因素。這些觀點與技術文獻、監管指南和公開的技術簡報進行交叉比對，以檢驗推斷出的趨勢和技術能力。

總結報告強調，需要集中投資於能力建構、合規性、檢驗和夥伴關係，以實現α粒子發射裝置應用的潛力。

總之，α放射性核素佔據著一個戰略意義重大且技術複雜的領域，其科學潛力與監管和營運現實交織在一起。同位素生產、發生器技術和檢測器性能的進步正在拓展其在治療、環境監測、工業測試和研究等領域的應用前景，而監管和貿易的發展也在重塑採購和供應鏈策略。相關人員採取綜合觀點，協調技術選擇、合規應對和供應韌性，將更有利於將科學機會轉化為可靠的專案成果。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 螯合技術的改進提高了基於錒-225的標靶α療法在癌症臨床試驗中的應用
  • 放射性藥物公司與學術中心建立策略夥伴關係，加速α粒子發射裝置的研究
  • 高純度α發射體供應鏈瓶頸促使各國投資發展國內同位素生產能力
  • 更新後的α放射性藥物法律規範為關鍵市場的快速批准鋪平了道路
  • 合成新型雙功能螯合劑以提高α粒子發射裝置的體內穩定性和腫瘤靶向效率
  • 釷-227放射免疫偶聯物的出現為抗藥性骨髓惡性腫瘤提供了一種新的治療選擇。
  • 透過製程強化和自動化技術實現α發射體製造的成本最佳化
  • 利用α粒子發射裝置和免疫調節劑進行聯合治療以增強抗癌反應的臨床前檢驗

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按應用分類的α發射體市場

  • 環境監測
    • 空氣監測
    • 土壤取樣
    • 水質監測
  • 工業檢驗
    • 無損檢測
    • 厚度測量
  • 藥物治療
    • 緩解疼痛
    • 標靶α療法
  • 研究與開發
    • 實驗室測試
    • 臨床前研究

9. 按最終用戶分類的 Alpha 發射器市場

  • 環境機構
  • 醫院診所
  • 工業無損檢測服務提供者
  • 研究所

第10章 按射極類型分類的α發射極市場

  • 錒-225
  • 鋂-241
  • 釙-210
  • 鐳-223

第11章 以裝置類型分類的α粒子發射裝置市場

  • 檢測器
    • 充氣式檢測器
    • 閃爍檢測器
    • 固體檢測器
  • 發電機
    • 筒式產生器
    • 列生成器
  • 輻射源
    • 密封輻射源
    • 未密封源

12. 以交付方式分類的α發射體市場

  • 複合材料
  • 液體溶液
    • 緩衝溶液
    • 生理食鹽水
  • 密封輻射源
    • 電鍍源
    • 薄膜源

第13章 依純度等級分類的α發射體市場

  • 大部分
  • 免費承運商
  • 非營運商免費

14. 依檢測技術分類的α粒子發射體市場

  • CdZnTe檢測器
  • 高純鍺檢測器
  • 電離室
  • NaI(Tl)閃爍體
  • 塑膠閃爍體
  • 比例計數器
  • 固體檢測器

第15章 各地區α發射體市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 α發射體市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國阿爾法發射體市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Bayer AG
    • Novartis AG
    • Curium Pharma
    • Telix Pharmaceuticals Limited
    • RayzeBio, Inc.
    • Actinium Pharmaceuticals, Inc.
    • Nordic Nanovector ASA
    • Fusion Pharmaceuticals Inc.
Product Code: MRR-742BD517A934

The Alpha Emitters Market is projected to grow by USD 4.81 billion at a CAGR of 20.80% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.06 billion
Estimated Year [2025] USD 1.28 billion
Forecast Year [2032] USD 4.81 billion
CAGR (%) 20.80%

Comprehensive introduction to alpha emitters highlighting scientific advances, regulatory dynamics, and operational considerations shaping strategic decisions

Alpha-emitting radionuclides have transitioned from niche scientific curiosities into pivotal tools across clinical, environmental, industrial, and research domains. This introduction frames the technical, regulatory, and commercial contours that define the present-day landscape, with attention to the interplay between innovation in radionuclide production and evolving requirements for safe handling, detection, and deployment. It clarifies the value proposition of alpha emitters: the unique radiobiological properties that enable highly localized energy deposition for therapy, and the signature signals that facilitate targeted environmental and industrial monitoring.

Over the last decade, improvements in isotope production pathways, generator technologies, and detector capabilities have reshaped practical access to and use of alpha emitters. Concurrently, regulatory authorities and institutional safety programs have tightened controls around sourcing, transport, and clinical application, creating both friction and opportunity. This introduction establishes the analytical lens used throughout the report: examining technological readiness, supply chain robustness, regulatory alignment, and end-user adoption dynamics. It emphasizes a pragmatic orientation-linking scientific capabilities to operational realities-so that decision-makers can prioritize investments that balance innovation with compliance and patient or environmental safety.

Finally, the introduction outlines how subsequent sections connect to one another. After situating the market forces and technological advances, the narrative proceeds to identify transformative shifts, assess policy-driven trade impacts, extract segmentation-driven insights, and present regional and competitive perspectives. The goal is to provide a cohesive foundation that supports strategic planning, partnership development, and risk mitigation for stakeholders across healthcare, environmental monitoring, industrial testing, and research sectors.

Transformative landscape shifts driven by technological breakthroughs, regulatory tightening, and resilient supply chain realignments reshaping alpha emitter adoption

The alpha emitters landscape is undergoing transformative shifts driven by converging forces in technology, policy, and demand. Breakthroughs in isotope production and generator design have reduced some historical bottlenecks, while advances in detector sensitivity and specificity have expanded feasible use cases in both clinical therapy and environmental surveillance. These technological improvements are complemented by increasing interest from clinical researchers exploring targeted alpha therapies, and from environmental and industrial practitioners seeking higher-fidelity detection capabilities.

Regulatory evolution is a parallel vector of change. Legislators and oversight bodies have responded to both safety concerns and therapeutic potential by tightening controls over transport, licensure, and clinical use. As a result, organizations are investing in compliance infrastructures, specialized handling protocols, and workforce training to meet more rigorous standards. This regulatory tightening, while introducing short-term complexity, is also raising overall confidence among institutional stakeholders and enabling more structured clinical trial programs and monitoring initiatives.

Supply chain dynamics constitute a third major shift. Greater attention to secure sourcing, onshoring, and diversification of production pathways is reshaping procurement strategies. Public and private actors alike are prioritizing resilient supply chains to reduce exposure to single-source vulnerabilities, particularly for high-value emitters used in therapy. Taken together, these technological, regulatory, and supply-chain shifts are transforming alpha emitters from specialized research inputs into strategically managed assets, prompting organizations to rethink partnerships, capital allocation, and long-term roadmaps.

Cumulative outcomes of United States trade measures in 2025 driving procurement reconfiguration, domestic capacity investment, and integrated supply chain risk mitigation

The introduction of new tariff measures in the United States in 2025 has had a cumulative influence on the alpha emitters ecosystem, affecting procurement planning, logistics, and cost structures for stakeholders across clinical, industrial, and research settings. Import duties and related trade policies have increased the transactional complexity for organizations that depend on international supply chains for isotopes, generator components, and specialized equipment. These measures have prompted procurement teams to reassess total landed cost considerations and to internalize risk premiums for delayed deliveries and customs-related compliance.

In response, some actors accelerated near-term investments in domestic production capabilities and strategic inventories to buffer against cross-border uncertainties. Such responses streamline continuity for critical clinical programs and industrial operations, but they also require capital and operational investments that alter deployment timelines and purchasing cycles. At the same time, tariff-driven cost pressures incentivized greater collaboration between suppliers and end users to negotiate supply agreements that incorporate shared risk mitigants, such as consignment models, scheduled replenishments, and joint investments in generator systems designed for longer in-field lifetime.

From an operational perspective, organizations recalibrated sourcing strategies, favoring suppliers with established logistics networks and transparent compliance practices. Many institutions intensified due diligence on vendor provenance, certificate-of-origin documentation, and customs handling capabilities. Overall, the 2025 tariff changes catalyzed a reorientation from transactional procurement toward integrated supply-chain partnerships, encouraging investments in domestic capabilities and more robust contractual safeguards to ensure continuity of clinical therapies, environmental monitoring programs, and industrial testing activities.

Deep segmentation insights connecting application needs, emitter types, equipment modalities, delivery formats, purity distinctions, and detection technologies for strategic alignment

Segmentation insights reveal differentiated value chains and adoption pathways that are essential for strategic planning. Considering application categories, environmental monitoring activities span air monitoring, soil sampling, and water monitoring and tend to prioritize detection sensitivity and regulatory compliance for long-term surveillance programs; industrial testing relies on non-destructive testing and thickness gauging where rugged detectors and standardized sources enable rapid, repeatable inspections; medical therapy encompasses pain palliation and targeted alpha therapy where stringent purity and clinical-grade production are paramount; research and development efforts cover clinical trials and preclinical research and demand both flexible sources and high-purity emitters for reproducible study conditions. These application-specific requirements shape procurement priorities, quality assurance practices, and technical specifications.

End-user perspectives further refine these distinctions. Environmental agencies emphasize regulatory alignment and community safety in monitoring deployments, hospitals and clinics focus on clinical workflows, dosimetry, and patient outcomes, industrial non-destructive testing providers prioritize operational throughput and equipment reliability, and research institutes require customizable sources and detection solutions to support experimental protocols. Each end user brings distinct expectations for supplier transparency, training, and after-sales support.

Emitter type selection is another pivotal segmentation axis. Actinium-225, Americium-241, Polonium-210, and Radium-223 each present unique production, handling, and application profiles that influence supply chain design and clinical or industrial adoption. Equipment type choices-detectors, generators, and sources-are differentiated by technical subtypes: detectors include gas-filled detectors, scintillation detectors, and solid state detectors; generators are available as cartridge generators or column generators; sources can be sealed or unsealed. These equipment distinctions affect operational workflows, maintenance regimes, and regulatory classification.

Delivery mode and formulation drive usability considerations. Composite materials, liquid solutions, and sealed sources represent different handling paradigms, and liquid solutions divided into buffered and saline formulations influence compatibility with clinical delivery systems. Sealed sources that are electroplated or manufactured as thin-film sources offer differing lifetimes and radiation profiles suited to industrial and calibration needs. Purity grade further stratifies the market into bulk, carrier-free, and no-carrier-added grades, each reflecting trade-offs between yield, chemical behavior, and suitability for therapeutic or analytical applications. Detection technique choices-spanning CdZnTe detectors, HPGe detectors, ionization chambers, NaI(Tl) scintillators, plastic scintillators, proportional counters, and solid state detectors-determine measurement precision, energy resolution, and operational complexity, directly informing capital expenditure and operational training requirements.

Synthesizing these segmentation dimensions highlights how technical characteristics, regulatory constraints, and end-user workflows coalesce to create distinct submarkets. Strategic decisions should therefore account for cross-segmentation interactions, such as how emitter type and purity grade inform generator selection and clinical applicability, or how detection technique and equipment form factor determine feasibility for field-based environmental monitoring versus centralized laboratory analysis.

Actionable regional insights illuminating how the Americas, Europe, Middle East & Africa, and Asia-Pacific exhibit distinct priorities for adoption, production, and regulation

Regional dynamics accentuate differing strategic priorities and execution pathways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced clinical research centers and industrial testing providers creates robust demand for high-purity emitters and sophisticated detection systems, alongside a regulatory environment that increasingly emphasizes supply security and clinical trial integrity. This drives investment in domestic capabilities and collaborative partnerships between academic centers, healthcare systems, and commercial suppliers to ensure continuity of therapeutic programs and monitoring initiatives.

Across Europe, Middle East & Africa, regulatory harmonization and cross-border cooperation influence procurement approaches, with a focus on standardized safety protocols and interoperable instrumentation that can be deployed across diverse jurisdictions. Regional initiatives that prioritize public health surveillance and environmental protection create steady demand for monitoring solutions, while certain markets in the Middle East and Africa pursue capacity building in clinical and industrial radioisotope use through targeted investments and knowledge-transfer partnerships.

In the Asia-Pacific region, rapid growth in clinical research activity and industrial modernization is prompting accelerated adoption of targeted therapies and advanced detection technologies. Many countries in the region are expanding local production capabilities and investing in training programs to support safe handling and clinical deployment. Supply chain diversification remains a regional priority, with governments and private actors seeking to reduce dependency on single-source imports and to cultivate domestic expertise in isotope production and generator manufacturing.

Taken together, these regional insights underscore the importance of aligning commercial strategies with localized regulatory frameworks, clinical and industrial priorities, and capacity-building trajectories. Organizations should therefore tailor go-to-market and partnership approaches to reflect each region's specific mix of demand drivers, infrastructure maturity, and policy environment.

Key company insights revealing differentiation through integrated supply chains, technology platforms, intellectual property, and service-led competitive positioning

Competitive dynamics in the alpha emitters domain are defined by a combination of technical expertise, regulatory experience, and the ability to deliver reliable supply chains. Leading actors differentiate themselves through integrated offerings that pair isotope production or generator manufacturing with validated detection technologies and comprehensive compliance services. Others focus on specialization-whether in high-purity production routes, scalable generator platforms, or ruggedized detectors for industrial environments. Strategic partnerships between producers, instrument manufacturers, and healthcare institutions are increasingly common, enabling expedited clinical trials, coordinated supply logistics, and shared risk structures.

In addition to vertical integration and partnerships, companies are investing in intellectual property around generator design, source encapsulation techniques, and detector materials to secure competitive advantage. Service capabilities such as training, after-sales maintenance, and regulatory support are central to value propositions, particularly for end users with limited in-house nuclear expertise. Furthermore, firms that can demonstrate robust quality management systems and traceable chain-of-custody procedures tend to gain preference in procurement decisions, as buyers prioritize safety and compliance alongside technical performance.

Market entrants face high technical and regulatory barriers, so successful growth strategies typically combine focused R&D investments with targeted alliances and pilot programs that validate performance in real-world clinical or industrial settings. Ultimately, competitive success will depend on the ability to integrate technical excellence with operational reliability, transparent compliance practices, and strong customer support models.

Actionable recommendations for industry leaders to build resilient supply chains, accelerate adoption, and align innovation with compliance and end-user needs

Leaders in the field should pursue a set of actionable priorities to convert opportunity into durable advantage. First, invest in resilient supply architectures that blend strategic inventory management with partnerships for domestic and nearshore production capabilities, thereby reducing exposure to cross-border disruptions and tariff-related volatility. Second, prioritize compliance and workforce readiness by building accredited training programs, robust quality control systems, and transparent documentation practices that align with evolving regulatory expectations.

Third, accelerate clinical and industrial adoption by funding targeted pilot programs and real-world validation studies that demonstrate safety, efficacy, and operational benefits. Such evidence will expedite institutional buy-in and inform procurement specifications. Fourth, design modular product and service offerings that accommodate diverse end-user needs-from field-deployable detection kits for environmental agencies to clinical-grade generators and liquid formulations for therapeutic programs-so that customers can scale solutions as their requirements evolve.

Fifth, cultivate partnerships across the value chain, including alliances with research institutions, instrumentation manufacturers, and logistics specialists, to co-develop solutions that address cross-functional constraints. Finally, commit to continuous innovation in detector materials, generator efficiency, and source encapsulation technologies while maintaining transparent communication about supply provenance and safety practices. Implementing these priorities will enable organizations to reduce risk, accelerate adoption, and capture strategic opportunities as the ecosystem matures.

Transparent, expert-driven research methodology integrating primary interviews, secondary validation, cross-segmentation synthesis, and scenario analysis for robust insights

The research methodology underpinning this report combines primary intelligence gathering, expert interviews, and rigorous secondary analysis to construct a multi-dimensional view of the alpha emitters landscape. Primary inputs include structured conversations with clinical researchers, environmental monitoring practitioners, industrial test engineers, equipment manufacturers, and regulatory specialists to capture real-world constraints and adoption drivers. These perspectives are triangulated with technical literature, regulatory guidance, and publicly available technical briefs to validate inferred trends and technological capabilities.

Analytical approaches emphasize cross-segmentation synthesis, examining how application requirements, emitter types, equipment modalities, delivery formats, purity grades, and detection techniques interact to produce distinct operational needs. The methodology also accounts for policy and trade influences, using scenario analysis to explore how tariff changes, regulatory updates, and supply chain disruptions could affect procurement and deployment strategies. Quality assurance steps include cross-verification of technical claims, review by subject-matter experts, and systematic documentation of assumptions to ensure traceability and reproducibility of findings.

Transparency about limitations is central to the methodology. Where public data are limited, estimates are informed by expert consensus and corroborated through multiple independent sources. The approach favors actionable insights over speculative assertions and is designed to equip decision-makers with clear, defensible reasoning that can be applied to strategy development, procurement planning, and collaborative initiatives.

Conclusive synthesis emphasizing coordinated investments in capacity, compliance, validation, and partnerships to realize the promise of alpha emitter applications

In conclusion, alpha emitters occupy a strategically important and technically complex domain where scientific potential intersects with regulatory and operational realities. Advances in isotope production, generator technologies, and detector capabilities are expanding feasible applications in therapy, environmental monitoring, industrial testing, and research, while regulatory and trade developments are reshaping procurement and supply-chain strategies. Stakeholders that adopt an integrated view-aligning technical selection, compliance readiness, and supply resilience-will be better positioned to translate scientific opportunity into reliable programmatic outcomes.

The journey from innovation to routine application requires coordinated action across multiple dimensions: investing in capacity and training, establishing resilient sourcing and logistics, validating performance through pilots and trials, and building trust through transparent quality and compliance practices. By focusing on these priorities and leveraging partnerships across the value chain, organizations can mitigate risk, accelerate adoption, and ensure that alpha emitters deliver their intended clinical, environmental, and industrial benefits in a safe and sustainable manner.

This conclusion invites stakeholders to use the detailed insights in the full report to inform strategic choices, operational investments, and collaborative initiatives that will determine how this technology fulfills its promise in the years ahead.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of actinium-225 based targeted alpha therapies in oncology trials driven by improved chelation methods
  • 5.2. Strategic partnerships between radiopharmaceutical firms and academic centers to accelerate alpha emitter research
  • 5.3. Supply chain bottlenecks for high-purity alpha emitters prompting investments in domestic isotope production capabilities
  • 5.4. Regulatory framework updates for alpha emitter radiopharmaceuticals shaping accelerated review pathways in major markets
  • 5.5. Integration of novel bifunctional chelators enhancing in vivo stability and tumor targeting efficiency of alpha emitters
  • 5.6. Emergence of thorium-227 radioimmunoconjugates offering new therapeutic options for resistant hematological malignancies
  • 5.7. Cost optimization initiatives in alpha emitter manufacturing through process intensification and automation technologies
  • 5.8. Preclinical validation of combination therapies pairing alpha emitters with immunomodulators to potentiate anticancer response

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Alpha Emitters Market, by Application

  • 8.1. Environmental Monitoring
    • 8.1.1. Air Monitoring
    • 8.1.2. Soil Sampling
    • 8.1.3. Water Monitoring
  • 8.2. Industrial Testing
    • 8.2.1. Non-Destructive Testing
    • 8.2.2. Thickness Gauging
  • 8.3. Medical Therapy
    • 8.3.1. Pain Palliation
    • 8.3.2. Targeted Alpha Therapy
  • 8.4. Research & Development
    • 8.4.1. Clinical Trials
    • 8.4.2. Preclinical Research

9. Alpha Emitters Market, by End User

  • 9.1. Environmental Agencies
  • 9.2. Hospitals & Clinics
  • 9.3. Industrial Non-Destructive Testing Providers
  • 9.4. Research Institutes

10. Alpha Emitters Market, by Emitter Type

  • 10.1. Actinium-225
  • 10.2. Americium-241
  • 10.3. Polonium-210
  • 10.4. Radium-223

11. Alpha Emitters Market, by Equipment Type

  • 11.1. Detectors
    • 11.1.1. Gas-Filled Detectors
    • 11.1.2. Scintillation Detectors
    • 11.1.3. Solid State Detectors
  • 11.2. Generators
    • 11.2.1. Cartridge Generators
    • 11.2.2. Column Generators
  • 11.3. Sources
    • 11.3.1. Sealed Sources
    • 11.3.2. Unsealed Sources

12. Alpha Emitters Market, by Delivery Mode

  • 12.1. Composite Materials
  • 12.2. Liquid Solutions
    • 12.2.1. Buffered Solutions
    • 12.2.2. Saline Solutions
  • 12.3. Sealed Sources
    • 12.3.1. Electroplated Sources
    • 12.3.2. Thin-Film Sources

13. Alpha Emitters Market, by Purity Grade

  • 13.1. Bulk
  • 13.2. Carrier-Free
  • 13.3. No-Carrier-Added

14. Alpha Emitters Market, by Detection Technique

  • 14.1. CdZnTe Detectors
  • 14.2. HPGe Detectors
  • 14.3. Ionization Chambers
  • 14.4. NaI(Tl) Scintillators
  • 14.5. Plastic Scintillators
  • 14.6. Proportional Counters
  • 14.7. Solid State Detectors

15. Alpha Emitters Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Alpha Emitters Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Alpha Emitters Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Bayer AG
    • 18.3.2. Novartis AG
    • 18.3.3. Curium Pharma
    • 18.3.4. Telix Pharmaceuticals Limited
    • 18.3.5. RayzeBio, Inc.
    • 18.3.6. Actinium Pharmaceuticals, Inc.
    • 18.3.7. Nordic Nanovector ASA
    • 18.3.8. Fusion Pharmaceuticals Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALPHA EMITTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. ALPHA EMITTERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. ALPHA EMITTERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ALPHA EMITTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ALPHA EMITTERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ALPHA EMITTERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ALPHA EMITTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AIR MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ALPHA EMITTERS MARKET SIZE, BY WATER MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NON-DESTRUCTIVE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THICKNESS GAUGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ALPHA EMITTERS MARKET SIZE, BY MEDICAL THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PAIN PALLIATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ALPHA EMITTERS MARKET SIZE, BY TARGETED ALPHA THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PRECLINICAL RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ALPHA EMITTERS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ALPHA EMITTERS MARKET SIZE, BY INDUSTRIAL NON-DESTRUCTIVE TESTING PROVIDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EMITTER TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ACTINIUM-225, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ALPHA EMITTERS MARKET SIZE, BY AMERICIUM-241, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ALPHA EMITTERS MARKET SIZE, BY POLONIUM-210, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ALPHA EMITTERS MARKET SIZE, BY RADIUM-223, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ALPHA EMITTERS MARKET SIZE, BY EQUIPMENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GAS-FILLED DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SCINTILLATION DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ALPHA EMITTERS MARKET SIZE, BY GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARTRIDGE GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COLUMN GENERATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ALPHA EMITTERS MARKET SIZE, BY UNSEALED SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ALPHA EMITTERS MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ALPHA EMITTERS MARKET SIZE, BY LIQUID SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BUFFERED SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SALINE SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SEALED SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ALPHA EMITTERS MARKET SIZE, BY ELECTROPLATED SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ALPHA EMITTERS MARKET SIZE, BY THIN-FILM SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PURITY GRADE, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ALPHA EMITTERS MARKET SIZE, BY BULK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CARRIER-FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NO-CARRIER-ADDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ALPHA EMITTERS MARKET SIZE, BY DETECTION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ALPHA EMITTERS MARKET SIZE, BY CDZNTE DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ALPHA EMITTERS MARKET SIZE, BY HPGE DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ALPHA EMITTERS MARKET SIZE, BY IONIZATION CHAMBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL ALPHA EMITTERS MARKET SIZE, BY NAI(TL) SCINTILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PLASTIC SCINTILLATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL ALPHA EMITTERS MARKET SIZE, BY PROPORTIONAL COUNTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 322. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 323. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. GLOBAL ALPHA EMITTERS MARKET SIZE, BY SOLID STATE DETECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL ALPHA EMITTERS MA